Big pharma to hit bottom

Daniel Grima from Cornerstone Research in Canada brought this news link to my attention. According to the numbers presented in the article, we are in for a very bumpy ride. The Wall Street Journal estimated that generics will be taken out $67 billion annual U.S. sales from the top pharmaceutical companies over the time frame 2007 to 2012. The alarming piece of news is that these $67 billion represent 50% of the total U.S. sales of those companies.

No comments: